PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Lansdowne Partners and Bpifrance lead EUR30.6m Series A funding round in Depixus

Depixus, a biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins, has raised EUR30.6 million in an oversubscribed Series A financing. 

Depixus, a biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins, has raised EUR30.6 million in an oversubscribed Series A financing. 

The round was co-led by Lansdowne Partners and the PSIM Fund operated by Bpifrance on behalf of the French State, with participation by Casdin Capital, and existing investors, including Arix Bioscience. This financing brings the company’s total equity and grant funding to-date to over EUR41 million (USD 47 million).

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured